GSK Says No Link Between Zofran, Defects Undermines MDL
Lawyers for GlaxoSmithKline argued Wednesday that more than 300 cases in a multidistrict product liability suit over its anti-nausea medication should be nixed since the plaintiffs' own expert determined there is...To view the full article, register now.
Already a subscriber? Click here to view full article